Member Info for Duggs999

Yes OGM good list.

The fact that you have a time critical result for stroke patient treatment a couple of days earlier than the lab test technically should save at least 2 days of each patient taking up a hospital bed. 1. at circa £350 per day NHS cost, and 2. the ethical benefit of freeing up those beds for patients stuck in ambulances queuing outside the UK hospital!

Win, win, win.

Carrots, totally agree the two products are literally goldmines. Both are the best available in their respective areas and have full UK approval! What is not to like.

The only thing holding this SP back is a clear commercialisation plan to turn the product potential into sales. Spend should be fully geared on 1. marketing and sales in all countries that accept UK device approval, 2. FDA approval for both kits.

R&D spent should take a backseat for now until the money starts rolling in.

I know many have already read this - but for those who haven't, this is well worth a look for shareholders here.

https://mft.nhs.uk/2024/07/31/manchester-leads-implementation-of-lifesaving-genetic-bedside-stroke-test/#:~:text=Developed%20by%20researchers%20from%20Manchester,benefit%20from%20clopidogrel%2C%20the%20current

Check out the HE1 board, may be a lot of sellers there - hopefully switching over to here today.

Agree with all Stephen, and chucked 25 large at it today - but only reticence is - with such a great pair of medical solutions, why aren't the UK recipients falling over themselves to adopt this tech quickly and place orders?

My view and conclusion is that this is typical of the UK sluggish response to 'everything' - and the orders will come eventually - in spades :)

That's me - and just now another 5 :)

50 day moving average provided good support at the 0.28 level - onwards and upwards.

Great news with FDA approval and NICE approval, but only £100K in new sales reported so far!

With the cash burn at £400K-£600K/month (as reported by the company in results RNS), the £6m raised in the spring is reducing quickly and without the sales to compensate for this.

Needs some decent new sales RNS's to get this to rise like it should be doing, otherwise???

Yeah, Joey and ihavenoclue it does change after the close on their website, but they change their trade signal advice when technical triggers are hit during the trading day.

If you join and pay the membership, the signal change is shared in real time for its members to choose to use it to update their investment or not.

New buy signal:

https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=GDR.L#google_vignette

Https://uk.investing.com/equities/epistem-holdings-plc-candlestick

Here is the gap closure, for those interested. Technical reason for dropping has now completed. Onwards and upwards.

For the 7am RNS ride.....

Nope, not the case at all. I'm looking to profit on HE1 and reinvest in GDR. Haven't deramped here at all - just pointed out the SP hitting the 200 day moving average resistance at 4.5p and made clear my short. I said then and still believe that a good news RNS will allow that resistance to be broken, properly. DYOR.

Closed at 4p last week and profit used to top up HE1 holding.

Massive RNS this morning there - BOOM. Take a look.

Tempted to close my 4.5p short. Nearly did at 3.5p but missed it.

I agree JH, where have you got gap closure sitting 3.3p, 3.5p?

If you only like backslappers posts you will get burnt. I'll be buying in the mid 3's with my short profits. Much better value than topping up in the 4's like many here.

Espen.i.s., change the record you boring little person.

BB99 - the company has had really good news regarding the FDA RNS and since near doubled in market cap value. It stalled at the 200day moving average and this was the reason I shorted. However with more news such at the NICE output - whenever that happens, yes I believe it could go north quickly and be a strong play.

It's musing that all the ramping posts get many. many, many recommends from all the hopeful backslappers. But anything other is detested.

Funny.

British industry and regulatory bodies = sluggish - at best. The market is not patient.

Get a room